116 related articles for article (PubMed ID: 28321024)
1. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Huang J; Li Y; Zhang J; Liu Y; Lu Q
Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium.
Ma Y; Zhang L; Edwards JN; Launikonis BS; Chen C
PLoS One; 2012; 7(4):e35265. PubMed ID: 22493744
[TBL] [Abstract][Full Text] [Related]
3. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
[TBL] [Abstract][Full Text] [Related]
4. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin plays a minor role in the physiological control of cardiac function in the rat.
Torsello A; Bresciani E; Rossoni G; Avallone R; Tulipano G; Cocchi D; Bulgarelli I; Deghenghi R; Berti F; Locatelli V
Endocrinology; 2003 May; 144(5):1787-92. PubMed ID: 12697684
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
Qian W; Zhao C; Li D; Dai R
Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
[TBL] [Abstract][Full Text] [Related]
8. Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.
Pang JJ; Xu RK; Xu XB; Cao JM; Ni C; Zhu WL; Asotra K; Chen MC; Chen C
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1063-9. PubMed ID: 14615277
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway.
Wang Q; Lin P; Li P; Feng L; Ren Q; Xie X; Xu J
Life Sci; 2017 Oct; 186():50-58. PubMed ID: 28782532
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury.
Zhu J; Huang J; Dai D; Wang X; Gao J; Han W; Zhang R
Biomed Pharmacother; 2019 Mar; 111():1-5. PubMed ID: 30551029
[TBL] [Abstract][Full Text] [Related]
12. Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat.
Pang J; Xu Q; Xu X; Yin H; Xu R; Guo S; Hao W; Wang L; Chen C; Cao JM
Peptides; 2010 Apr; 31(4):630-8. PubMed ID: 19931584
[TBL] [Abstract][Full Text] [Related]
13. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
14. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction.
Mao Y; Tokudome T; Kishimoto I; Otani K; Hosoda H; Nagai C; Minamino N; Miyazato M; Kangawa K
Endocrinology; 2013 Oct; 154(10):3847-54. PubMed ID: 23861368
[TBL] [Abstract][Full Text] [Related]
15. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
[TBL] [Abstract][Full Text] [Related]
16. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart.
Ma Y; Zhang L; Launikonis BS; Chen C
Endocrinology; 2012 Nov; 153(11):5480-90. PubMed ID: 22948211
[TBL] [Abstract][Full Text] [Related]
18. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
Cardiologia; 1997 Nov; 42(11):1165-72. PubMed ID: 9534309
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin ameliorates impaired angiogenesis of ischemic myocardium through GHSR1a-mediated AMPK/eNOS signal pathway in diabetic rats.
Wang L; Chen Q; Li G; Ke D
Peptides; 2015 Nov; 73():77-87. PubMed ID: 26364514
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus.
Biagini G; Torsello A; Marinelli C; Gualtieri F; Vezzali R; Coco S; Bresciani E; Locatelli V
Eur J Pharmacol; 2011 Nov; 670(1):130-6. PubMed ID: 21914437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
